Omeprazol Farmoz (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Farmoz, is a proton pump inhibitor presented as a oral formulation for systemic use. It reduces gastric acid secretion and is used to manage acid‑related disorders in adults and children. GNH USA supplies Omeprazol Farmoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Farmoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Farmoz is a proton pump inhibitor that acts on the gastric acid secretion pathway to treat several acid‑related conditions.

- Gastro‑esophageal reflux disease (GERD): alleviates heartburn and esophageal irritation by maintaining a higher gastric pH. - Peptic ulcer disease: promotes ulcer healing by reducing acid exposure to the gastric lining. - NSAID‑induced ulcer prophylaxis: lowers the risk of ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens by creating a less acidic gastric environment.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild, transient headache reported in clinical use. - Diarrhea: loose stools that usually resolve without intervention. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis associated with antibiotic‑like dysbiosis. - Acute interstitial nephritis: sudden kidney inflammation presenting with reduced urine output. - Severe hypersensitivity reactions: rash, angioedema, or anaphylaxis. - Osteoporotic fractures: increased risk with long‑term use, particularly in the hip, wrist or spine. - Vitamin B12 deficiency: reduced absorption leading to anemia with prolonged therapy. - Hepatic injury: rare cases of elevated liver enzymes or hepatitis.

Before initiating therapy, consider the following precautions:

- Assess renal function: dose adjustment may be required in severe impairment. - Evaluate hepatic status: use with caution in patients with liver disease. - Review concomitant medications: potential for drug‑drug interactions. - Pregnancy and lactation: discuss risks and benefits with a healthcare professional. - Long‑term therapy: monitor for bone density loss and vitamin B12 levels. - Store at ambient temperature: keep below 25°C, protect from moisture and light in the original packaging.

Omeprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect may increase cardiovascular risk. - Atorvastatin: increased serum concentrations can raise the risk of myopathy. - Methotrexate: higher systemic exposure may enhance toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR; monitor coagulation parameters. - Digoxin: increased levels may require dose adjustment. - Phenytoin: reduced clearance may lead to toxicity. - Ketoconazole: decreased absorption due to higher gastric pH.